Pulmatrix Inc
(NASDAQ : PULM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.45%193.601.2%$599.84m
GILDGilead Sciences, Inc.
-0.87%66.980.9%$498.93m
CELGCelgene Corporation
1.54%67.781.2%$483.99m
BIIBBiogen Inc.
-0.65%317.411.3%$463.13m
ILMNIllumina, Inc.
2.52%308.683.5%$396.36m
REGNRegeneron Pharmaceuticals, Inc.
1.48%342.292.6%$295.94m
VRTXVertex Pharmaceuticals Incorporated
0.75%160.951.9%$260.45m
AAgilent Technologies, Inc.
1.13%68.281.5%$218.37m
ALXNAlexion Pharmaceuticals, Inc.
1.66%118.762.0%$203.88m
SRPTSarepta Therapeutics, Inc.
-0.38%116.7315.4%$145.45m
LGNDLigand Pharmaceuticals Incorporated
2.34%152.3523.1%$140.62m
EXASExact Sciences Corporation
2.89%66.6025.3%$134.28m
TSROTESARO, Inc.
-3.48%41.0014.4%$133.90m
NKTRNektar Therapeutics
-1.94%37.385.6%$119.60m
INCYIncyte Corporation
0.53%63.932.5%$113.56m

Company Profile

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The company focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Edwards, Mark Gabrielson, Alexander Klibanov, and Robert Langer on June 15, 2015 and is headquartered in Lexington, MA.